Enrico Maffini
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Journal: Bone marrow transplantation
Published: March 21, 2026
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.
Journal: The Journal of antimicrobial chemotherapy
Published: February 11, 2026
Prospective observational study of magnetic resonance imaging in anti-CD19 CAR T-cell-associated neurotoxicity.
Journal: Journal of neurology
Published: November 25, 2025
Assessment of CMV infection in allo-HSCT recipients undergoing LMV prophylaxis by using an implemented diagnostic protocol to identify active viral replication.
Journal: Antiviral research
Published: October 07, 2025
Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Journal: Bone marrow transplantation
Published: September 14, 2025
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy.
Journal: Journal of neurology
Published: February 16, 2025
Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib.
Journal: Mediterranean journal of hematology and infectious diseases
Published: February 06, 2025
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 04, 2024
Epigenetic age acceleration in hematopoietic stem cell transplantation.
Journal: Haematologica
Published: March 20, 2024
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome.
Journal: Haematologica
Published: February 27, 2024
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Journal: Bone marrow transplantation
Published: February 16, 2024
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 16, 2024
Last Updated: 09/26/2026